nodes	percent_of_prediction	percent_of_DWPC	metapath
Ciclopirox—Skin burning sensation—Crizotinib—lung cancer	0.099	0.106	CcSEcCtD
Ciclopirox—Burning sensation—Crizotinib—lung cancer	0.0348	0.0373	CcSEcCtD
Ciclopirox—Nail disorder—Gefitinib—lung cancer	0.0338	0.0362	CcSEcCtD
Ciclopirox—Ventricular tachycardia—Pemetrexed—lung cancer	0.0221	0.0237	CcSEcCtD
Ciclopirox—Skin exfoliation—Pemetrexed—lung cancer	0.0211	0.0226	CcSEcCtD
Ciclopirox—Nail disorder—Erlotinib—lung cancer	0.0202	0.0217	CcSEcCtD
Ciclopirox—Eye pain—Gefitinib—lung cancer	0.0176	0.0189	CcSEcCtD
Ciclopirox—Face oedema—Crizotinib—lung cancer	0.0169	0.0181	CcSEcCtD
Ciclopirox—Dry skin—Gefitinib—lung cancer	0.0146	0.0156	CcSEcCtD
Ciclopirox—ATP1A1—mammary gland—lung cancer	0.0141	0.212	CbGeAlD
Ciclopirox—Skin exfoliation—Erlotinib—lung cancer	0.0125	0.0134	CcSEcCtD
Ciclopirox—Nail disorder—Etoposide—lung cancer	0.012	0.0129	CcSEcCtD
Ciclopirox—Nail disorder—Paclitaxel—lung cancer	0.0118	0.0126	CcSEcCtD
Ciclopirox—Skin exfoliation—Vinorelbine—lung cancer	0.0108	0.0116	CcSEcCtD
Ciclopirox—Nail disorder—Docetaxel—lung cancer	0.00997	0.0107	CcSEcCtD
Ciclopirox—Alopecia—Pemetrexed—lung cancer	0.0098	0.0105	CcSEcCtD
Ciclopirox—Alopecia—Gefitinib—lung cancer	0.00974	0.0104	CcSEcCtD
Ciclopirox—Erythema—Pemetrexed—lung cancer	0.00965	0.0103	CcSEcCtD
Ciclopirox—ATP1A1—respiratory system—lung cancer	0.0094	0.141	CbGeAlD
Ciclopirox—Burning sensation—Docetaxel—lung cancer	0.00931	0.00997	CcSEcCtD
Ciclopirox—Unspecified disorder of skin and subcutaneous tissue—Crizotinib—lung cancer	0.00893	0.00957	CcSEcCtD
Ciclopirox—Dry skin—Erlotinib—lung cancer	0.00873	0.00935	CcSEcCtD
Ciclopirox—Skin exfoliation—Gemcitabine—lung cancer	0.0087	0.00932	CcSEcCtD
Ciclopirox—Skin disorder—Crizotinib—lung cancer	0.00837	0.00897	CcSEcCtD
Ciclopirox—Unspecified disorder of skin and subcutaneous tissue—Pemetrexed—lung cancer	0.00816	0.00874	CcSEcCtD
Ciclopirox—Unspecified disorder of skin and subcutaneous tissue—Gefitinib—lung cancer	0.00811	0.00869	CcSEcCtD
Ciclopirox—Skin exfoliation—Cisplatin—lung cancer	0.00811	0.00869	CcSEcCtD
Ciclopirox—Alopecia—Teniposide—lung cancer	0.00794	0.0085	CcSEcCtD
Ciclopirox—ATP1A1—epithelium—lung cancer	0.00786	0.118	CbGeAlD
Ciclopirox—ATP1A1—bronchus—lung cancer	0.00774	0.116	CbGeAlD
Ciclopirox—Skin disorder—Pemetrexed—lung cancer	0.00765	0.0082	CcSEcCtD
Ciclopirox—Ventricular tachycardia—Paclitaxel—lung cancer	0.00763	0.00817	CcSEcCtD
Ciclopirox—Skin disorder—Gefitinib—lung cancer	0.0076	0.00815	CcSEcCtD
Ciclopirox—Skin exfoliation—Etoposide—lung cancer	0.00743	0.00796	CcSEcCtD
Ciclopirox—Skin exfoliation—Paclitaxel—lung cancer	0.00728	0.0078	CcSEcCtD
Ciclopirox—Nail disorder—Methotrexate—lung cancer	0.00719	0.0077	CcSEcCtD
Ciclopirox—ATP1A1—trachea—lung cancer	0.00695	0.104	CbGeAlD
Ciclopirox—Pain—Pemetrexed—lung cancer	0.00674	0.00722	CcSEcCtD
Ciclopirox—Burning sensation—Methotrexate—lung cancer	0.00671	0.00719	CcSEcCtD
Ciclopirox—Pain—Gefitinib—lung cancer	0.00669	0.00717	CcSEcCtD
Ciclopirox—ATP1A1—cardiac atrium—lung cancer	0.00653	0.0982	CbGeAlD
Ciclopirox—Face oedema—Gemcitabine—lung cancer	0.00639	0.00684	CcSEcCtD
Ciclopirox—Nail disorder—Doxorubicin—lung cancer	0.00622	0.00667	CcSEcCtD
Ciclopirox—Skin exfoliation—Docetaxel—lung cancer	0.00617	0.00661	CcSEcCtD
Ciclopirox—Eye pain—Paclitaxel—lung cancer	0.00613	0.00657	CcSEcCtD
Ciclopirox—Alopecia—Vinblastine—lung cancer	0.00606	0.00649	CcSEcCtD
Ciclopirox—Immune system disorder—Topotecan—lung cancer	0.00601	0.00644	CcSEcCtD
Ciclopirox—Face oedema—Cisplatin—lung cancer	0.00595	0.00638	CcSEcCtD
Ciclopirox—Alopecia—Topotecan—lung cancer	0.00588	0.0063	CcSEcCtD
Ciclopirox—Alopecia—Erlotinib—lung cancer	0.00582	0.00624	CcSEcCtD
Ciclopirox—Burning sensation—Doxorubicin—lung cancer	0.00581	0.00622	CcSEcCtD
Ciclopirox—Erythema—Erlotinib—lung cancer	0.00573	0.00614	CcSEcCtD
Ciclopirox—Pruritus—Pemetrexed—lung cancer	0.00557	0.00597	CcSEcCtD
Ciclopirox—Pruritus—Gefitinib—lung cancer	0.00554	0.00593	CcSEcCtD
Ciclopirox—ATP1A1—bone marrow—lung cancer	0.00551	0.0829	CbGeAlD
Ciclopirox—Rash—Crizotinib—lung cancer	0.00544	0.00582	CcSEcCtD
Ciclopirox—Dermatitis—Crizotinib—lung cancer	0.00543	0.00582	CcSEcCtD
Ciclopirox—Immune system disorder—Vinorelbine—lung cancer	0.00514	0.00551	CcSEcCtD
Ciclopirox—Dry skin—Paclitaxel—lung cancer	0.00508	0.00544	CcSEcCtD
Ciclopirox—Alopecia—Vinorelbine—lung cancer	0.00503	0.00539	CcSEcCtD
Ciclopirox—ATP1A1—lung—lung cancer	0.00499	0.0751	CbGeAlD
Ciclopirox—Rash—Pemetrexed—lung cancer	0.00497	0.00532	CcSEcCtD
Ciclopirox—Dermatitis—Pemetrexed—lung cancer	0.00496	0.00532	CcSEcCtD
Ciclopirox—Erythema—Vinorelbine—lung cancer	0.00496	0.00531	CcSEcCtD
Ciclopirox—Rash—Gefitinib—lung cancer	0.00494	0.00529	CcSEcCtD
Ciclopirox—Dermatitis—Gefitinib—lung cancer	0.00493	0.00528	CcSEcCtD
Ciclopirox—Unspecified disorder of skin and subcutaneous tissue—Topotecan—lung cancer	0.0049	0.00525	CcSEcCtD
Ciclopirox—Unspecified disorder of skin and subcutaneous tissue—Erlotinib—lung cancer	0.00485	0.00519	CcSEcCtD
Ciclopirox—Skin disorder—Topotecan—lung cancer	0.00459	0.00492	CcSEcCtD
Ciclopirox—Skin disorder—Erlotinib—lung cancer	0.00455	0.00487	CcSEcCtD
Ciclopirox—Pruritus—Teniposide—lung cancer	0.00452	0.00484	CcSEcCtD
Ciclopirox—Skin exfoliation—Methotrexate—lung cancer	0.00445	0.00477	CcSEcCtD
Ciclopirox—Dry skin—Docetaxel—lung cancer	0.0043	0.00461	CcSEcCtD
Ciclopirox—Immune system disorder—Irinotecan—lung cancer	0.00424	0.00455	CcSEcCtD
Ciclopirox—Unspecified disorder of skin and subcutaneous tissue—Vinorelbine—lung cancer	0.00419	0.00449	CcSEcCtD
Ciclopirox—Pain—Vinblastine—lung cancer	0.00416	0.00446	CcSEcCtD
Ciclopirox—Alopecia—Irinotecan—lung cancer	0.00415	0.00445	CcSEcCtD
Ciclopirox—Immune system disorder—Gemcitabine—lung cancer	0.00413	0.00443	CcSEcCtD
Ciclopirox—Pain—Topotecan—lung cancer	0.00405	0.00433	CcSEcCtD
Ciclopirox—Alopecia—Gemcitabine—lung cancer	0.00404	0.00433	CcSEcCtD
Ciclopirox—Ventricular tachycardia—Doxorubicin—lung cancer	0.00404	0.00432	CcSEcCtD
Ciclopirox—Rash—Teniposide—lung cancer	0.00402	0.00431	CcSEcCtD
Ciclopirox—Dermatitis—Teniposide—lung cancer	0.00402	0.00431	CcSEcCtD
Ciclopirox—Pain—Erlotinib—lung cancer	0.004	0.00429	CcSEcCtD
Ciclopirox—Headache—Teniposide—lung cancer	0.004	0.00428	CcSEcCtD
Ciclopirox—Dermatitis contact—Doxorubicin—lung cancer	0.00399	0.00427	CcSEcCtD
Ciclopirox—Erythema—Gemcitabine—lung cancer	0.00398	0.00427	CcSEcCtD
Ciclopirox—Skin disorder—Vinorelbine—lung cancer	0.00393	0.00421	CcSEcCtD
Ciclopirox—Skin exfoliation—Doxorubicin—lung cancer	0.00385	0.00413	CcSEcCtD
Ciclopirox—Immune system disorder—Cisplatin—lung cancer	0.00385	0.00413	CcSEcCtD
Ciclopirox—Alopecia—Cisplatin—lung cancer	0.00377	0.00404	CcSEcCtD
Ciclopirox—Erythema—Cisplatin—lung cancer	0.00371	0.00398	CcSEcCtD
Ciclopirox—Immune system disorder—Etoposide—lung cancer	0.00353	0.00378	CcSEcCtD
Ciclopirox—Pain—Vinorelbine—lung cancer	0.00346	0.00371	CcSEcCtD
Ciclopirox—Immune system disorder—Paclitaxel—lung cancer	0.00346	0.00371	CcSEcCtD
Ciclopirox—Alopecia—Etoposide—lung cancer	0.00345	0.0037	CcSEcCtD
Ciclopirox—ATP1A1—lymph node—lung cancer	0.00341	0.0514	CbGeAlD
Ciclopirox—Alopecia—Paclitaxel—lung cancer	0.00339	0.00363	CcSEcCtD
Ciclopirox—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—lung cancer	0.00337	0.00361	CcSEcCtD
Ciclopirox—Pruritus—Topotecan—lung cancer	0.00335	0.00359	CcSEcCtD
Ciclopirox—Erythema—Paclitaxel—lung cancer	0.00333	0.00357	CcSEcCtD
Ciclopirox—Pruritus—Erlotinib—lung cancer	0.00331	0.00355	CcSEcCtD
Ciclopirox—Eczema—Doxorubicin—lung cancer	0.00326	0.00349	CcSEcCtD
Ciclopirox—Eye pain—Doxorubicin—lung cancer	0.00324	0.00348	CcSEcCtD
Ciclopirox—Skin disorder—Gemcitabine—lung cancer	0.00316	0.00338	CcSEcCtD
Ciclopirox—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—lung cancer	0.00314	0.00336	CcSEcCtD
Ciclopirox—Headache—Vinblastine—lung cancer	0.00305	0.00327	CcSEcCtD
Ciclopirox—Rash—Topotecan—lung cancer	0.00298	0.00319	CcSEcCtD
Ciclopirox—Dermatitis—Topotecan—lung cancer	0.00298	0.00319	CcSEcCtD
Ciclopirox—Headache—Topotecan—lung cancer	0.00296	0.00317	CcSEcCtD
Ciclopirox—Rash—Erlotinib—lung cancer	0.00295	0.00316	CcSEcCtD
Ciclopirox—Dermatitis—Erlotinib—lung cancer	0.00295	0.00316	CcSEcCtD
Ciclopirox—Skin disorder—Cisplatin—lung cancer	0.00294	0.00315	CcSEcCtD
Ciclopirox—Immune system disorder—Docetaxel—lung cancer	0.00293	0.00314	CcSEcCtD
Ciclopirox—Headache—Erlotinib—lung cancer	0.00293	0.00314	CcSEcCtD
Ciclopirox—Unspecified disorder of skin and subcutaneous tissue—Etoposide—lung cancer	0.00288	0.00308	CcSEcCtD
Ciclopirox—Alopecia—Docetaxel—lung cancer	0.00287	0.00307	CcSEcCtD
Ciclopirox—Pruritus—Vinorelbine—lung cancer	0.00286	0.00307	CcSEcCtD
Ciclopirox—Pain—Irinotecan—lung cancer	0.00285	0.00306	CcSEcCtD
Ciclopirox—Face oedema—Doxorubicin—lung cancer	0.00283	0.00303	CcSEcCtD
Ciclopirox—Erythema—Docetaxel—lung cancer	0.00283	0.00303	CcSEcCtD
Ciclopirox—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—lung cancer	0.00282	0.00302	CcSEcCtD
Ciclopirox—Pain—Gemcitabine—lung cancer	0.00278	0.00298	CcSEcCtD
Ciclopirox—Skin disorder—Etoposide—lung cancer	0.0027	0.00289	CcSEcCtD
Ciclopirox—Dry skin—Doxorubicin—lung cancer	0.00269	0.00288	CcSEcCtD
Ciclopirox—Skin disorder—Paclitaxel—lung cancer	0.00264	0.00283	CcSEcCtD
Ciclopirox—Pain—Cisplatin—lung cancer	0.00259	0.00278	CcSEcCtD
Ciclopirox—Rash—Vinorelbine—lung cancer	0.00255	0.00273	CcSEcCtD
Ciclopirox—Dermatitis—Vinorelbine—lung cancer	0.00255	0.00273	CcSEcCtD
Ciclopirox—Headache—Vinorelbine—lung cancer	0.00253	0.00272	CcSEcCtD
Ciclopirox—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	0.00239	0.00256	CcSEcCtD
Ciclopirox—Pain—Etoposide—lung cancer	0.00237	0.00254	CcSEcCtD
Ciclopirox—Pain—Paclitaxel—lung cancer	0.00233	0.00249	CcSEcCtD
Ciclopirox—Pruritus—Gemcitabine—lung cancer	0.0023	0.00246	CcSEcCtD
Ciclopirox—Skin disorder—Docetaxel—lung cancer	0.00224	0.0024	CcSEcCtD
Ciclopirox—Immune system disorder—Methotrexate—lung cancer	0.00211	0.00226	CcSEcCtD
Ciclopirox—Rash—Irinotecan—lung cancer	0.0021	0.00225	CcSEcCtD
Ciclopirox—Dermatitis—Irinotecan—lung cancer	0.0021	0.00225	CcSEcCtD
Ciclopirox—Headache—Irinotecan—lung cancer	0.00209	0.00224	CcSEcCtD
Ciclopirox—Alopecia—Methotrexate—lung cancer	0.00207	0.00222	CcSEcCtD
Ciclopirox—Rash—Gemcitabine—lung cancer	0.00205	0.0022	CcSEcCtD
Ciclopirox—Dermatitis—Gemcitabine—lung cancer	0.00205	0.00219	CcSEcCtD
Ciclopirox—Erythema—Methotrexate—lung cancer	0.00204	0.00218	CcSEcCtD
Ciclopirox—Headache—Gemcitabine—lung cancer	0.00204	0.00218	CcSEcCtD
Ciclopirox—Pain—Docetaxel—lung cancer	0.00197	0.00211	CcSEcCtD
Ciclopirox—Pruritus—Etoposide—lung cancer	0.00196	0.0021	CcSEcCtD
Ciclopirox—Pruritus—Paclitaxel—lung cancer	0.00193	0.00206	CcSEcCtD
Ciclopirox—Rash—Cisplatin—lung cancer	0.00191	0.00205	CcSEcCtD
Ciclopirox—Dermatitis—Cisplatin—lung cancer	0.00191	0.00204	CcSEcCtD
Ciclopirox—Immune system disorder—Doxorubicin—lung cancer	0.00183	0.00196	CcSEcCtD
Ciclopirox—Alopecia—Doxorubicin—lung cancer	0.00179	0.00192	CcSEcCtD
Ciclopirox—Erythema—Doxorubicin—lung cancer	0.00176	0.00189	CcSEcCtD
Ciclopirox—Rash—Etoposide—lung cancer	0.00175	0.00187	CcSEcCtD
Ciclopirox—Dermatitis—Etoposide—lung cancer	0.00175	0.00187	CcSEcCtD
Ciclopirox—Headache—Etoposide—lung cancer	0.00174	0.00186	CcSEcCtD
Ciclopirox—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	0.00172	0.00185	CcSEcCtD
Ciclopirox—Rash—Paclitaxel—lung cancer	0.00172	0.00184	CcSEcCtD
Ciclopirox—Dermatitis—Paclitaxel—lung cancer	0.00171	0.00184	CcSEcCtD
Ciclopirox—Headache—Paclitaxel—lung cancer	0.00171	0.00183	CcSEcCtD
Ciclopirox—Pruritus—Docetaxel—lung cancer	0.00163	0.00175	CcSEcCtD
Ciclopirox—Skin disorder—Methotrexate—lung cancer	0.00162	0.00173	CcSEcCtD
Ciclopirox—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	0.00149	0.0016	CcSEcCtD
Ciclopirox—Rash—Docetaxel—lung cancer	0.00145	0.00156	CcSEcCtD
Ciclopirox—Dermatitis—Docetaxel—lung cancer	0.00145	0.00156	CcSEcCtD
Ciclopirox—Headache—Docetaxel—lung cancer	0.00145	0.00155	CcSEcCtD
Ciclopirox—Pain—Methotrexate—lung cancer	0.00142	0.00152	CcSEcCtD
Ciclopirox—Skin disorder—Doxorubicin—lung cancer	0.0014	0.0015	CcSEcCtD
Ciclopirox—Pain—Doxorubicin—lung cancer	0.00123	0.00132	CcSEcCtD
Ciclopirox—Pruritus—Methotrexate—lung cancer	0.00118	0.00126	CcSEcCtD
Ciclopirox—Rash—Methotrexate—lung cancer	0.00105	0.00112	CcSEcCtD
Ciclopirox—Dermatitis—Methotrexate—lung cancer	0.00105	0.00112	CcSEcCtD
Ciclopirox—Headache—Methotrexate—lung cancer	0.00104	0.00112	CcSEcCtD
Ciclopirox—Pruritus—Doxorubicin—lung cancer	0.00102	0.00109	CcSEcCtD
Ciclopirox—Rash—Doxorubicin—lung cancer	0.000908	0.000972	CcSEcCtD
Ciclopirox—Dermatitis—Doxorubicin—lung cancer	0.000907	0.000972	CcSEcCtD
Ciclopirox—Headache—Doxorubicin—lung cancer	0.000902	0.000966	CcSEcCtD
